A phase 2 umbrella study of retifanlimab (incmga00012) alone or in combination with other therapies in patients with advanced or metastatic endometrial cancer (pod1um-204)
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined